Research article · 2013
Conference abstractPublished 19 Nov 2012
Cancer suicide gene therapy: Apoptosis of the ovarian cancer cells induced by EGFRvIII targeted delivery and cell nucleus targeted expression of the DNA-ase transgenes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Malignant ovarian cancers are the most deadly of all diseases of the reproductive system. Radical oopherectomy in advanced cancer leads to complete infertility. Fertility sparing surgery followed by systemic therapies may result in infertility of the patients and/or the genetic mutations in oocytes potentially leading to genetic disorders of the offspring. The specific aim of this work was to refine our cancer suicide gene therapy, so the apoptosis is sharply restricted to the ovarian cancer cells only. To attain this aim, we genetically engineered single chain variable fragments targeting EGFRvIII receptors, which are present on the cancer cells only. We also engineered the DNAase having the optimum for it activity at the cell nucleus environment, while having it expressed under the ovary specific promoters. We tested the specificity of delivery with the in situ PCR, immunoPCR, FCM, and NMR. We validated induction of apoptosis with the FCM, qPCR, EELS and EDXS. Upon delivery to the mixed cell cultures spiked with the human ovarian cancers, the cell spheroids, and xenografts in nude mice, the transgenes were very selectively delivered only to the cells expressing EGFRvIII. Moreover, the transgenes were effectively expressed in the targeted ovarian cancer cells. The suicide transgenes induced effective degradation of the genomic DNA within the human ovarian cancer cells only. We demonstrated that the cancer suicide gene therapy through targeted expression of recombinant DNAase is very specific in eliminating cancer cells, while leaving the healthy cells unharmed.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 15 Apr 2014
Plant peptide lectin-coated gold nanoparticles cytotoxicity against targeted tumor associated carbohydrate antigen expressed in cancer cell lines: A potential application in drug delivery
Commentary · 2013
Targeted Transgenic RNAi Knockdown of Cell Fate Determinants Induces Neoplastic Tumor Growth and Metastasis in a Drosophila Transplantation Model of Neural Stem Cell Derived Cancer
Research article · 8 Mar 2017
MiR-214 regulates oral cancer KB cell apoptosis through targeting RASSF5
Conference abstract
Therapeutic targeting of ovarian cancer stem cells
More from this journal
The newest in Journal of Genetic Syndromes & Gene Therapy.
Commentary · 1 Jul 2026
Mitochondrial Genome Correction Approaches in Rare Energy Deficiency Syndromes
Perspective · 1 Jul 2026
Lentiviral Gene Integration Systems in Hematologic Genetic Blood Disorders
Perspective · 1 Jul 2026
Programmable RNA Editing Systems in Congenital Skeletal Dysplasia Disorders
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Genetic Syndromes & Gene Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Marek Malecki”

